SCHEMBL13640241

SCHEMBL13640241

CC(C)c1cccc(C(C)(O)C(C)C)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.57
GABRB2 P47870 3/20 0.57
CA2 P00918 3/20 0.57
CYP3A4 P08684 3/20 0.57
GABRG2 P18507 2/20 0.57
GABRB3 P28472 2/20 0.57
CA1 P00915 2/20 0.57
CYP1A2 P05177 2/20 0.57
FAAH O00519 1/20 0.57
LMNA P02545 1/20 0.57
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.57
GABRB1 P18505 1/20 0.57
PTGS1 P23219 1/20 0.57
SLC6A2 P23975 1/20 0.57
HTR2C P28335 1/20 0.57
GABRA5 P31644 1/20 0.57
GABRA3 P34903 1/20 0.57
HTR2B P41595 1/20 0.57
GABRA2 P47869 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56957 0.82 GABRA1 (0.64) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL7745836 0.82 GABRA1 (0.64) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL19236658 0.77 CYP3A4 (0.39) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL4912818 0.77 GABRA1 (0.61) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL13583692 0.76 GABRA1 (0.55) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL17537237 0.76 GABRA1 (0.50) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL11208550 0.75 GABRA1 (0.53) GABRA1GABRB2CA2CYP3A4GABRG2
SCHEMBL10775084 0.75 GABRA1 (0.53) GABRA1GABRB2CA2CYP3A4GABRG2
Propofol SCHEMBL2414429 0.75 GABRA1 (1.00) GABRA1GABRB2CA2CYP3A4GABRG2
Propofol SCHEMBL36245 0.75 GABRA1 (1.00) GABRA1GABRB2CA2CYP3A4GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics SIGNATURE THERAPEUTICS, INC. 2012-11-08 US disclosed
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics SIGNATURE THERAPEUTICS, INC. 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics GABRP, CYP4F11, CYP2F1 GABRA1 14/4885GABRB2 67/4885CA2 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.